Pharmaceutical Industry – Euractiv https://www.euractiv.com News & EU policy from Europe, for Europe Thu, 23 May 2024 15:24:32 +0000 en-GB hourly 1 https://www.euractiv.com/wp-content/uploads/sites/2/2023/12/cropped-cropped-Brand-avatar-_-CMYK-1-32x32.jpg Pharmaceutical Industry – Euractiv https://www.euractiv.com 32 32 EU needs to catch up with US in research and development, lobby warns https://www.euractiv.com/section/health-consumers/news/eu-needs-to-catch-up-with-us-in-research-and-development-lobby-warns/ Fri, 17 May 2024 11:52:55 +0000 https://www.euractiv.com/?post_type=news&p=2093337 French industry minister Lescure welcomes Italian pharma company Chiesi’s investment in France https://www.euractiv.com/section/health-consumers/news/french-industry-minister-lescure-welcomes-italian-pharma-company-chiesis-investment-in-france/ Tue, 14 May 2024 14:13:31 +0000 https://www.euractiv.com/?post_type=news&p=2091308 France: Europe’s highest tax burden for pharma industry, lobby warns https://www.euractiv.com/section/health-consumers/news/france-europes-highest-tax-burden-for-pharma-industry-lobby-warns/ Thu, 02 May 2024 15:31:25 +0000 https://www.euractiv.com/?post_type=news&p=2086556 French Greens’ top candidate wants ‘European pharmaceutical sovereignty’ https://www.euractiv.com/section/health-consumers/news/french-greens-top-candidate-wants-european-pharmaceutical-sovereignty/ Fri, 19 Apr 2024 14:49:57 +0000 https://www.euractiv.com/?post_type=news&p=2080354 Shaping the future of Europe’s healthcare in a new political cycle [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/shaping-the-future-of-europes-healthcare-in-a-new-political-cycle/ Fri, 12 Apr 2024 15:56:21 +0000 https://www.euractiv.com/?post_type=news&p=2076419 Limiting competition in medicines is not an option https://www.euractiv.com/section/health-consumers/opinion/limiting-competition-in-medicines-is-not-an-option/ Thu, 15 Feb 2024 11:40:42 +0000 https://www.euractiv.com/?post_type=news&p=2047816 Europe’s biotech innovation in the balance https://www.euractiv.com/section/health-consumers/news/europes-biotech-innovation-in-the-balance/ Mon, 05 Feb 2024 01:19:09 +0000 https://www.euractiv.com/?post_type=news&p=2040965 LEAK: Commission enlists help of stakeholders to reshape EU pharma sector https://www.euractiv.com/section/health-consumers/news/leak-commission-enlists-help-of-stakeholders-to-reshape-eu-pharma-sector/ Wed, 26 Apr 2023 05:15:01 +0000 https://www.euractiv.com/?post_type=news&p=1914789 Delay of EU pharma reform faces criticism from MEPs, stakeholders https://www.euractiv.com/section/health-consumers/news/delay-of-eu-pharma-reform-faces-criticism-from-meps-stakeholders/ Thu, 23 Mar 2023 17:23:29 +0000 https://www.euractiv.com/?post_type=news&p=1898997 EU pharma reform delayed again due to Commission’s busy agenda https://www.euractiv.com/section/health-consumers/news/eu-pharma-reform-delayed-again-due-to-commissions-busy-agenda/ Wed, 22 Mar 2023 16:11:16 +0000 https://www.euractiv.com/?post_type=news&p=1898314 Commission to seek patient-centred, industry-friendly pharma rules reform https://www.euractiv.com/section/health-consumers/news/commission-to-seek-patient-centred-industry-friendly-pharma-rules-reform/ Tue, 14 Mar 2023 10:45:03 +0000 https://www.euractiv.com/?post_type=news&p=1893601 How the AI Act could unintentionally impact access to healthcare [Promoted content] https://www.euractiv.com/section/digital/opinion/how-the-ai-act-could-unintentionally-impact-access-to-healthcare/ Wed, 01 Mar 2023 06:00:48 +0000 https://www.euractiv.com/?post_type=opinion&p=1886235 Health experts challenge inequitable distribution of new medicines across EU https://www.euractiv.com/section/health-consumers/news/health-experts-challenge-inequitable-distribution-of-new-medicines-across-eu/ Wed, 02 Nov 2022 18:38:32 +0000 https://www.euractiv.com/?post_type=news&p=1833623 Italy could become a reference point for biotechnology in health care also for its know-how [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/italy-could-become-a-reference-point-for-biotechnology-in-health-care-also-for-its-know-how/ Tue, 25 Oct 2022 10:00:02 +0000 https://www.euractiv.com/?post_type=opinion&p=1827967 High hopes for EU’s health biotech sector after COVID boost https://www.euractiv.com/section/health-consumers/news/high-hopes-for-eus-health-biotech-after-covid-boost/ Mon, 17 Oct 2022 18:31:13 +0000 https://www.euractiv.com/?post_type=news&p=1825926 Unleashing the biotech potential in health https://www.euractiv.com/section/health-consumers/special_report/unleashing-the-biotech-potential-in-health/ Mon, 17 Oct 2022 18:31:02 +0000 https://www.euractiv.com/?post_type=special_report&p=1818298 Pharma CEO: Gap between EU vision and national competencies affects health agenda https://www.euractiv.com/section/health-consumers/interview/pharma-ceo-gap-between-eu-vision-and-national-competencies-affects-health-agenda/ Tue, 12 Jul 2022 13:33:34 +0000 https://www.euractiv.com/?post_type=news&p=1785882 Revision of orphan and paediatric drug framework needed, say reports https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/revision-of-orphan-and-paediatric-drug-framework-needed-say-reports/ https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/revision-of-orphan-and-paediatric-drug-framework-needed-say-reports/#respond Mon, 07 Mar 2022 07:00:37 +0000 https://www.euractiv.com/?post_type=news&p=1722256 https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/revision-of-orphan-and-paediatric-drug-framework-needed-say-reports/feed/ 0 Commission: Pharma companies need incentives to develop orphan drugs https://www.euractiv.com/section/health-consumers/news/commission-pharma-companies-need-incentives-to-develop-orphan-drugs/ https://www.euractiv.com/section/health-consumers/news/commission-pharma-companies-need-incentives-to-develop-orphan-drugs/#respond Fri, 28 Jan 2022 08:19:00 +0000 https://www.euractiv.com/?post_type=news&p=1704169 https://www.euractiv.com/section/health-consumers/news/commission-pharma-companies-need-incentives-to-develop-orphan-drugs/feed/ 0 €2.4 bn ‘Innovative Health Initiative’ to better address current health issues https://www.euractiv.com/section/health-consumers/news/e2-4-bn-innovative-health-initiative-to-better-address-current-health-issues/ https://www.euractiv.com/section/health-consumers/news/e2-4-bn-innovative-health-initiative-to-better-address-current-health-issues/#respond Thu, 27 Jan 2022 07:15:16 +0000 https://www.euractiv.com/?post_type=news&p=1703664 https://www.euractiv.com/section/health-consumers/news/e2-4-bn-innovative-health-initiative-to-better-address-current-health-issues/feed/ 0 MEPs call for the EU pharma strategy to address medicine shortages https://www.euractiv.com/section/health-consumers/news/meps-call-for-the-eu-pharma-strategy-to-address-medicine-shortages/ https://www.euractiv.com/section/health-consumers/news/meps-call-for-the-eu-pharma-strategy-to-address-medicine-shortages/#respond Thu, 14 Oct 2021 12:53:31 +0000 https://www.euractiv.fr/?post_type=news&p=621728 https://www.euractiv.com/section/health-consumers/news/meps-call-for-the-eu-pharma-strategy-to-address-medicine-shortages/feed/ 0 Pharma rules overhaul steals scene of EU’s 2022 health agenda https://www.euractiv.com/section/health-consumers/news/pharma-rules-overhaul-steals-scene-of-eus-2022-health-agenda/ https://www.euractiv.com/section/health-consumers/news/pharma-rules-overhaul-steals-scene-of-eus-2022-health-agenda/#respond Thu, 07 Oct 2021 05:48:58 +0000 https://www.euractiv.com/?post_type=news&p=1656294 https://www.euractiv.com/section/health-consumers/news/pharma-rules-overhaul-steals-scene-of-eus-2022-health-agenda/feed/ 0 EU action to turn the AMR tide looks at different incentive models https://www.euractiv.com/section/health-consumers/news/eu-action-to-turn-the-amr-tide-looks-at-different-incentive-models/ https://www.euractiv.com/section/health-consumers/news/eu-action-to-turn-the-amr-tide-looks-at-different-incentive-models/#respond Fri, 23 Jul 2021 15:14:45 +0000 https://www.euractiv.com/?post_type=news&p=1630685 https://www.euractiv.com/section/health-consumers/news/eu-action-to-turn-the-amr-tide-looks-at-different-incentive-models/feed/ 0 Time to put healthcare at the heart of the digital age https://www.euractiv.com/section/health-consumers/opinion/time-to-put-healthcare-at-the-heart-of-the-digital-age/ https://www.euractiv.com/section/health-consumers/opinion/time-to-put-healthcare-at-the-heart-of-the-digital-age/#comments Thu, 10 Jun 2021 21:45:23 +0000 https://www.euractiv.com/?post_type=opinion&p=1614958 https://www.euractiv.com/section/health-consumers/opinion/time-to-put-healthcare-at-the-heart-of-the-digital-age/feed/ 1 Antimicrobial resistance – a silent pandemic requiring global action now https://www.euractiv.com/section/health-consumers/opinion/antimicrobial-resistance-a-silent-pandemic-requiring-global-action-now/ https://www.euractiv.com/section/health-consumers/opinion/antimicrobial-resistance-a-silent-pandemic-requiring-global-action-now/#comments Wed, 26 May 2021 09:36:59 +0000 https://www.euractiv.com/?post_type=opinion&p=1609265 https://www.euractiv.com/section/health-consumers/opinion/antimicrobial-resistance-a-silent-pandemic-requiring-global-action-now/feed/ 1 MEP: Parliament will pressure Commission to focus on nanomedicines https://www.euractiv.com/section/health-consumers/news/mep-parliament-will-pressure-commission-to-focus-on-nanomedicines/ https://www.euractiv.com/section/health-consumers/news/mep-parliament-will-pressure-commission-to-focus-on-nanomedicines/#respond Tue, 08 Dec 2020 09:01:17 +0000 https://www.euractiv.com/?post_type=news&p=1542353 https://www.euractiv.com/section/health-consumers/news/mep-parliament-will-pressure-commission-to-focus-on-nanomedicines/feed/ 0 EU ponders new incentives for novel antibiotics https://www.euractiv.com/section/health-consumers/news/eu-ponders-new-incentives-for-novel-antibiotics/ https://www.euractiv.com/section/health-consumers/news/eu-ponders-new-incentives-for-novel-antibiotics/#respond Wed, 25 Nov 2020 15:55:00 +0000 https://www.euractiv.com/?post_type=news&p=1536881 https://www.euractiv.com/section/health-consumers/news/eu-ponders-new-incentives-for-novel-antibiotics/feed/ 0 EU leaked pharma strategy pushes innovation for a resilient Europe https://www.euractiv.com/section/health-consumers/news/eu-leaked-pharma-strategy-pushes-on-innovation-for-resilient-future/ https://www.euractiv.com/section/health-consumers/news/eu-leaked-pharma-strategy-pushes-on-innovation-for-resilient-future/#respond Tue, 24 Nov 2020 07:46:35 +0000 https://www.euractiv.com/?post_type=news&p=1535898 https://www.euractiv.com/section/health-consumers/news/eu-leaked-pharma-strategy-pushes-on-innovation-for-resilient-future/feed/ 0 COVID-19 further complicated ‘biggest cancer killer’ diagnosis https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/covid-19-further-complicated-biggest-cancer-killer-diagnosis/ https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/covid-19-further-complicated-biggest-cancer-killer-diagnosis/#respond Fri, 13 Nov 2020 11:00:47 +0000 https://www.euractiv.com/?post_type=news&p=1531556 https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/covid-19-further-complicated-biggest-cancer-killer-diagnosis/feed/ 0 Economist: ‘Premature’ to decide changes in Orphan Drugs law https://www.euractiv.com/section/health-consumers/news/economist-premature-to-decide-changes-in-orphan-drugs-law/ https://www.euractiv.com/section/health-consumers/news/economist-premature-to-decide-changes-in-orphan-drugs-law/#respond Thu, 12 Nov 2020 10:50:40 +0000 https://www.euractiv.com/?post_type=news&p=1531056 https://www.euractiv.com/section/health-consumers/news/economist-premature-to-decide-changes-in-orphan-drugs-law/feed/ 0 Innovation and patients at the core of EU orphan drugs law review https://www.euractiv.com/section/health-consumers/special_report/innovation-and-patients-at-the-core-of-eu-orphan-drugs-law-review/ https://www.euractiv.com/section/health-consumers/special_report/innovation-and-patients-at-the-core-of-eu-orphan-drugs-law-review/#respond Tue, 03 Nov 2020 14:43:01 +0000 https://www.euractiv.com/?post_type=special_report&p=1525987 https://www.euractiv.com/section/health-consumers/special_report/innovation-and-patients-at-the-core-of-eu-orphan-drugs-law-review/feed/ 0 Report: Without orphan drugs law, 2mn patients deprived access to therapies https://www.euractiv.com/section/health-consumers/news/report-without-orphan-drugs-law-2mn-patients-deprived-access-to-therapies/ https://www.euractiv.com/section/health-consumers/news/report-without-orphan-drugs-law-2mn-patients-deprived-access-to-therapies/#respond Tue, 03 Nov 2020 14:40:17 +0000 https://www.euractiv.com/?post_type=news&p=1527311 https://www.euractiv.com/section/health-consumers/news/report-without-orphan-drugs-law-2mn-patients-deprived-access-to-therapies/feed/ 0 Commission urged to consider common regulatory framework for nanomedicines https://www.euractiv.com/section/health-consumers/news/commission-urged-to-consider-common-regulatory-framework-for-nanomedicines/ https://www.euractiv.com/section/health-consumers/news/commission-urged-to-consider-common-regulatory-framework-for-nanomedicines/#respond Thu, 17 Sep 2020 12:15:54 +0000 https://www.euractiv.com/?post_type=news&p=1507662 https://www.euractiv.com/section/health-consumers/news/commission-urged-to-consider-common-regulatory-framework-for-nanomedicines/feed/ 0 Poor investment in digitising health hit Europe back with COVID-19 https://www.euractiv.com/section/coronavirus/news/poor-investment-in-digitising-health-hit-europe-back-with-covid-19/ https://www.euractiv.com/section/coronavirus/news/poor-investment-in-digitising-health-hit-europe-back-with-covid-19/#comments Tue, 15 Sep 2020 11:10:18 +0000 https://www.euractiv.com/?post_type=news&p=1506513 https://www.euractiv.com/section/coronavirus/news/poor-investment-in-digitising-health-hit-europe-back-with-covid-19/feed/ 1 COVID-19: Time to show citizens that they can count on Europe https://www.euractiv.com/section/coronavirus/opinion/covid-19-time-to-show-citizens-that-they-can-count-on-europe/ https://www.euractiv.com/section/coronavirus/opinion/covid-19-time-to-show-citizens-that-they-can-count-on-europe/#respond Mon, 14 Sep 2020 12:44:00 +0000 https://www.euractiv.com/?post_type=opinion&p=1505859 https://www.euractiv.com/section/coronavirus/opinion/covid-19-time-to-show-citizens-that-they-can-count-on-europe/feed/ 0 Early stakeholder dialogues crucial for success of rare orphan medicines https://www.euractiv.com/section/health-consumers/news/early-stakeholder-dialogues-crucial-for-success-of-rare-orphan-medicines/ https://www.euractiv.com/section/health-consumers/news/early-stakeholder-dialogues-crucial-for-success-of-rare-orphan-medicines/#comments Thu, 23 Jul 2020 10:13:58 +0000 https://www.euractiv.com/?post_type=news&p=1492036 https://www.euractiv.com/section/health-consumers/news/early-stakeholder-dialogues-crucial-for-success-of-rare-orphan-medicines/feed/ 1 Taking action on the global threat of superbugs https://www.euractiv.com/section/health-consumers/opinion/taking-action-on-the-global-threat-of-superbugs/ https://www.euractiv.com/section/health-consumers/opinion/taking-action-on-the-global-threat-of-superbugs/#respond Thu, 09 Jul 2020 12:30:07 +0000 https://www.euractiv.com/?post_type=opinion&p=1487151 https://www.euractiv.com/section/health-consumers/opinion/taking-action-on-the-global-threat-of-superbugs/feed/ 0 MEP: A common EU tool to incentivise production and availability of orphan drugs https://www.euractiv.com/section/health-consumers/news/mep-a-common-eu-tool-to-incentivise-production-and-availability-of-orphan-drugs/ https://www.euractiv.com/section/health-consumers/news/mep-a-common-eu-tool-to-incentivise-production-and-availability-of-orphan-drugs/#respond Thu, 09 Jul 2020 05:20:19 +0000 https://www.euractiv.com/?post_type=news&p=1486872 https://www.euractiv.com/section/health-consumers/news/mep-a-common-eu-tool-to-incentivise-production-and-availability-of-orphan-drugs/feed/ 0 Reviewing orphan drugs law: A tough equation https://www.euractiv.com/section/health-consumers/special_report/reviewing-orphan-drugs-law-a-tough-equation/ https://www.euractiv.com/section/health-consumers/special_report/reviewing-orphan-drugs-law-a-tough-equation/#respond Mon, 06 Jul 2020 06:27:18 +0000 https://www.euractiv.com/?post_type=special_report&p=1485624 https://www.euractiv.com/section/health-consumers/special_report/reviewing-orphan-drugs-law-a-tough-equation/feed/ 0 Commission’s ‘risky’ move to re-visit orphan drugs regulation https://www.euractiv.com/section/health-consumers/news/commissions-risky-move-to-re-visit-orphan-drugs-regulation/ https://www.euractiv.com/section/health-consumers/news/commissions-risky-move-to-re-visit-orphan-drugs-regulation/#comments Mon, 06 Jul 2020 05:49:19 +0000 https://www.euractiv.com/?post_type=news&p=1485842 https://www.euractiv.com/section/health-consumers/news/commissions-risky-move-to-re-visit-orphan-drugs-regulation/feed/ 1 NGOs call for moratorium on controversial ‘gene drive organisms’ https://www.euractiv.com/section/health-consumers/news/ngos-call-for-moratorium-on-controversial-gene-drive-organisms/ https://www.euractiv.com/section/health-consumers/news/ngos-call-for-moratorium-on-controversial-gene-drive-organisms/#comments Fri, 03 Jul 2020 12:45:51 +0000 https://www.euractiv.com/?post_type=news&p=1485511 https://www.euractiv.com/section/health-consumers/news/ngos-call-for-moratorium-on-controversial-gene-drive-organisms/feed/ 1 Franco-German couple sets eyes on EU health sovereignty https://www.euractiv.com/section/health-consumers/news/franco-german-couple-sets-eyes-on-eu-health-sovereignty/ https://www.euractiv.com/section/health-consumers/news/franco-german-couple-sets-eyes-on-eu-health-sovereignty/#respond Tue, 19 May 2020 06:56:47 +0000 https://www.euractiv.com/?post_type=news&p=1468085 https://www.euractiv.com/section/health-consumers/news/franco-german-couple-sets-eyes-on-eu-health-sovereignty/feed/ 0 Oxfam: COVID-19 vaccinations for vulnerable could cost fraction of top pharma’s yearly profits https://www.euractiv.com/section/health-consumers/news/oxfam-covid-19-vaccinations-for-vulnerable-could-cost-fraction-of-top-pharmas-yearly-profits/ https://www.euractiv.com/section/health-consumers/news/oxfam-covid-19-vaccinations-for-vulnerable-could-cost-fraction-of-top-pharmas-yearly-profits/#respond Thu, 14 May 2020 11:05:37 +0000 https://www.euractiv.com/?post_type=news&p=1466540 https://www.euractiv.com/section/health-consumers/news/oxfam-covid-19-vaccinations-for-vulnerable-could-cost-fraction-of-top-pharmas-yearly-profits/feed/ 0 New health tools for COVID-19 https://www.euractiv.com/section/coronavirus/opinion/new-health-tools-for-covid-19/ https://www.euractiv.com/section/coronavirus/opinion/new-health-tools-for-covid-19/#respond Mon, 04 May 2020 14:33:56 +0000 https://www.euractiv.com/?post_type=opinion&p=1462168 https://www.euractiv.com/section/coronavirus/opinion/new-health-tools-for-covid-19/feed/ 0 Commission aims to bring back medicine production to Europe https://www.euractiv.com/section/health-consumers/news/commission-aims-to-bring-back-medicine-production-to-europe/ https://www.euractiv.com/section/health-consumers/news/commission-aims-to-bring-back-medicine-production-to-europe/#respond Wed, 22 Apr 2020 08:51:35 +0000 https://www.euractiv.com/?post_type=news&p=1457599 https://www.euractiv.com/section/health-consumers/news/commission-aims-to-bring-back-medicine-production-to-europe/feed/ 0 Pharma boss: EU will have to focus on long-term medical research ecosystem https://www.euractiv.com/section/coronavirus/interview/pharma-boss-eu-will-have-to-focus-on-long-term-medical-research-ecosystem/ https://www.euractiv.com/section/coronavirus/interview/pharma-boss-eu-will-have-to-focus-on-long-term-medical-research-ecosystem/#respond Mon, 23 Mar 2020 06:51:42 +0000 https://www.euractiv.com/?post_type=interview&p=1445708 https://www.euractiv.com/section/coronavirus/interview/pharma-boss-eu-will-have-to-focus-on-long-term-medical-research-ecosystem/feed/ 0 Commission’s new Pharmaceutical Strategy wants to touch core issues https://www.euractiv.com/section/health-consumers/news/commissions-new-pharmaceutical-strategy-wants-to-touch-core-issues/ https://www.euractiv.com/section/health-consumers/news/commissions-new-pharmaceutical-strategy-wants-to-touch-core-issues/#respond Thu, 12 Mar 2020 15:12:42 +0000 https://www.euractiv.com/?post_type=news&p=1441026 https://www.euractiv.com/section/health-consumers/news/commissions-new-pharmaceutical-strategy-wants-to-touch-core-issues/feed/ 0 ‘This is personal’: Von der Leyen launches consultation on EU’s Cancer Plan https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/this-is-personal-von-der-leyen-launches-eus-beating-cancer-plan/ https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/this-is-personal-von-der-leyen-launches-eus-beating-cancer-plan/#respond Wed, 05 Feb 2020 07:41:56 +0000 https://www.euractiv.com/?post_type=news&p=1426909 https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/this-is-personal-von-der-leyen-launches-eus-beating-cancer-plan/feed/ 0 EU health sector ‘up to a decade’ behind others for digitalisation, Commission says https://www.euractiv.com/section/health-consumers/news/eu-health-sector-up-to-a-decade-behind-others-for-digitalisation-commission-says/ https://www.euractiv.com/section/health-consumers/news/eu-health-sector-up-to-a-decade-behind-others-for-digitalisation-commission-says/#respond Wed, 06 Nov 2019 16:29:03 +0000 https://www.euractiv.com/?post_type=news&p=1398319 https://www.euractiv.com/section/health-consumers/news/eu-health-sector-up-to-a-decade-behind-others-for-digitalisation-commission-says/feed/ 0 New EU Commission should take on rheumatic and musculoskeletal diseases https://www.euractiv.com/section/health-consumers/news/new-eu-commission-should-take-head-on-rheumatic-and-musculoskeletal-diseases/ https://www.euractiv.com/section/health-consumers/news/new-eu-commission-should-take-head-on-rheumatic-and-musculoskeletal-diseases/#comments Fri, 25 Oct 2019 08:04:43 +0000 https://www.euractiv.com/?post_type=news&p=1395040 https://www.euractiv.com/section/health-consumers/news/new-eu-commission-should-take-head-on-rheumatic-and-musculoskeletal-diseases/feed/ 2 EU cancer plan will succeed if the right priorities are identified, official says https://www.euractiv.com/section/health-consumers/news/eu-cancer-plan-will-succeed-if-the-right-priorities-are-identified-official-says/ https://www.euractiv.com/section/health-consumers/news/eu-cancer-plan-will-succeed-if-the-right-priorities-are-identified-official-says/#respond Mon, 14 Oct 2019 06:24:32 +0000 https://www.euractiv.com/?post_type=news&p=1390194 https://www.euractiv.com/section/health-consumers/news/eu-cancer-plan-will-succeed-if-the-right-priorities-are-identified-official-says/feed/ 0 Healthy vaccines ecosystem: A tough equation to solve https://www.euractiv.com/section/health-consumers/news/healthy-vaccines-ecosystem-a-tough-equation-to-solve/ https://www.euractiv.com/section/health-consumers/news/healthy-vaccines-ecosystem-a-tough-equation-to-solve/#respond Tue, 08 Oct 2019 05:08:46 +0000 https://www.euractiv.com/?post_type=news&p=1388063 https://www.euractiv.com/section/health-consumers/news/healthy-vaccines-ecosystem-a-tough-equation-to-solve/feed/ 0 Measles hit Zagreb as social media join fight against anti-vaccination https://www.euractiv.com/section/health-consumers/news/measles-hit-zagreb-as-social-media-join-fight-against-anti-vaccination/ https://www.euractiv.com/section/health-consumers/news/measles-hit-zagreb-as-social-media-join-fight-against-anti-vaccination/#respond Tue, 24 Sep 2019 11:55:10 +0000 https://www.euractiv.com/?post_type=news&p=1376548 https://www.euractiv.com/section/health-consumers/news/measles-hit-zagreb-as-social-media-join-fight-against-anti-vaccination/feed/ 0 Better access to health innovation is Kyriakides’ top priority (and hardest task) https://www.euractiv.com/section/health-consumers/news/better-access-to-health-innovation-is-kyriakides-top-priority-and-hardest-task/ https://www.euractiv.com/section/health-consumers/news/better-access-to-health-innovation-is-kyriakides-top-priority-and-hardest-task/#respond Wed, 11 Sep 2019 09:46:19 +0000 https://www.euractiv.com/?post_type=news&p=1373313 https://www.euractiv.com/section/health-consumers/news/better-access-to-health-innovation-is-kyriakides-top-priority-and-hardest-task/feed/ 0 What European patients need: a shot of some good old Belgian surrealism https://www.euractiv.com/section/health-consumers/opinion/what-european-patients-need-a-shot-of-some-good-old-belgian-surrealism/ https://www.euractiv.com/section/health-consumers/opinion/what-european-patients-need-a-shot-of-some-good-old-belgian-surrealism/#comments Mon, 26 Aug 2019 13:59:07 +0000 https://www.euractiv.com/?post_type=opinion&p=1368664 https://www.euractiv.com/section/health-consumers/opinion/what-european-patients-need-a-shot-of-some-good-old-belgian-surrealism/feed/ 1 Czech drug policy shifts toward patients with rare diseases https://www.euractiv.com/section/health-consumers/interview/czech-drug-policy-shifts-toward-patients-with-rare-diseases/ https://www.euractiv.com/section/health-consumers/interview/czech-drug-policy-shifts-toward-patients-with-rare-diseases/#respond Thu, 11 Jul 2019 09:51:23 +0000 https://www.euractiv.com/?post_type=news&p=1359130 https://www.euractiv.com/section/health-consumers/interview/czech-drug-policy-shifts-toward-patients-with-rare-diseases/feed/ 0 New pharma boss: Next EU Commission should be clear on how to protect innovation https://www.euractiv.com/section/health-consumers/news/new-pharma-boss-next-eu-commission-should-be-clear-on-how-to-protect-innovation/ https://www.euractiv.com/section/health-consumers/news/new-pharma-boss-next-eu-commission-should-be-clear-on-how-to-protect-innovation/#comments Fri, 28 Jun 2019 08:58:04 +0000 https://www.euractiv.com/?post_type=news&p=1355187 https://www.euractiv.com/section/health-consumers/news/new-pharma-boss-next-eu-commission-should-be-clear-on-how-to-protect-innovation/feed/ 1 EU should tackle health inequality with investments: MSD official https://www.euractiv.com/section/health-consumers/news/eu-should-tackle-health-inequality-with-investments-msd-official/ https://www.euractiv.com/section/health-consumers/news/eu-should-tackle-health-inequality-with-investments-msd-official/#comments Fri, 07 Jun 2019 05:12:00 +0000 https://www.euractiv.com/?post_type=news&p=1348176 https://www.euractiv.com/section/health-consumers/news/eu-should-tackle-health-inequality-with-investments-msd-official/feed/ 1 Pharma incentives reform is for the next Commission, EU official says https://www.euractiv.com/section/health-consumers/news/pharma-incentives-reform-is-for-the-next-commission-eu-official-says/ https://www.euractiv.com/section/health-consumers/news/pharma-incentives-reform-is-for-the-next-commission-eu-official-says/#respond Wed, 05 Jun 2019 13:57:06 +0000 https://www.euractiv.com/?post_type=news&p=1347321 https://www.euractiv.com/section/health-consumers/news/pharma-incentives-reform-is-for-the-next-commission-eu-official-says/feed/ 0 AMR incentives could be next big EU opportunity, pharma boss says https://www.euractiv.com/section/health-consumers/news/amr-incentives-could-be-next-big-eu-opportunity-pharma-boss-says/ https://www.euractiv.com/section/health-consumers/news/amr-incentives-could-be-next-big-eu-opportunity-pharma-boss-says/#comments Wed, 29 May 2019 05:59:00 +0000 https://www.euractiv.com/?post_type=news&p=1345435 https://www.euractiv.com/section/health-consumers/news/amr-incentives-could-be-next-big-eu-opportunity-pharma-boss-says/feed/ 1 Katainen: Same level of priority for food and medicine in no-deal Brexit https://www.euractiv.com/section/health-consumers/news/katainen-same-level-of-priority-for-food-and-medicine-in-no-deal-scenario/ https://www.euractiv.com/section/health-consumers/news/katainen-same-level-of-priority-for-food-and-medicine-in-no-deal-scenario/#comments Fri, 05 Apr 2019 06:56:08 +0000 https://www.euractiv.com/?post_type=news&p=1329751 https://www.euractiv.com/section/health-consumers/news/katainen-same-level-of-priority-for-food-and-medicine-in-no-deal-scenario/feed/ 2 Pharma industry urges EU leaders to ‘re-focus’ on patients post-Brexit https://www.euractiv.com/section/health-consumers/news/pharma-industry-urges-eu-leaders-to-re-focus-on-patients-post-brexit/ https://www.euractiv.com/section/health-consumers/news/pharma-industry-urges-eu-leaders-to-re-focus-on-patients-post-brexit/#respond Wed, 20 Mar 2019 14:36:52 +0000 https://www.euractiv.com/?post_type=news&p=1324596 https://www.euractiv.com/section/health-consumers/news/pharma-industry-urges-eu-leaders-to-re-focus-on-patients-post-brexit/feed/ 0 Report from two EU agencies confirms superbugs as a rising threat https://www.euractiv.com/section/health-consumers/news/report-from-two-eu-agencies-confirms-superbugs-as-a-rising-threat/ https://www.euractiv.com/section/health-consumers/news/report-from-two-eu-agencies-confirms-superbugs-as-a-rising-threat/#respond Tue, 26 Feb 2019 10:00:30 +0000 https://www.euractiv.com/?post_type=news&p=1317168 https://www.euractiv.com/section/health-consumers/news/report-from-two-eu-agencies-confirms-superbugs-as-a-rising-threat/feed/ 0 EU pharma stakeholders take action to tackle fake medicines https://www.euractiv.com/section/health-consumers/news/eu-pharma-stakeholders-take-action-to-tackle-fake-medicines/ https://www.euractiv.com/section/health-consumers/news/eu-pharma-stakeholders-take-action-to-tackle-fake-medicines/#respond Mon, 11 Feb 2019 12:16:41 +0000 https://www.euractiv.com/?post_type=news&p=1312235 https://www.euractiv.com/section/health-consumers/news/eu-pharma-stakeholders-take-action-to-tackle-fake-medicines/feed/ 0 Pharma industry raises the alarm about stockpiling of generic drugs https://www.euractiv.com/section/health-consumers/news/pharma-industry-raises-the-alarm-about-stockpiling-of-generic-drugs/ https://www.euractiv.com/section/health-consumers/news/pharma-industry-raises-the-alarm-about-stockpiling-of-generic-drugs/#respond Tue, 29 Jan 2019 08:30:27 +0000 https://www.euractiv.com/?post_type=news&p=1308689 https://www.euractiv.com/section/health-consumers/news/pharma-industry-raises-the-alarm-about-stockpiling-of-generic-drugs/feed/ 0 New anti-microbial resistance business models are off the table, Romanian health minister says https://www.euractiv.com/section/health-consumers/news/new-anti-microbial-resistance-business-models-are-off-the-table-romanian-health-minister-says/ https://www.euractiv.com/section/health-consumers/news/new-anti-microbial-resistance-business-models-are-off-the-table-romanian-health-minister-says/#comments Thu, 24 Jan 2019 05:49:17 +0000 https://www.euractiv.com/?post_type=news&p=1307051 https://www.euractiv.com/section/health-consumers/news/new-anti-microbial-resistance-business-models-are-off-the-table-romanian-health-minister-says/feed/ 1 Discussion heats up over stockpiling of generic drugs under patent protection https://www.euractiv.com/section/health-consumers/news/discussion-heats-up-over-stockpiling-of-generic-drugs-under-patent-protection/ https://www.euractiv.com/section/health-consumers/news/discussion-heats-up-over-stockpiling-of-generic-drugs-under-patent-protection/#respond Mon, 21 Jan 2019 07:27:26 +0000 https://www.euractiv.com/?post_type=news&p=1306081 https://www.euractiv.com/section/health-consumers/news/discussion-heats-up-over-stockpiling-of-generic-drugs-under-patent-protection/feed/ 0 Disparities remain on how to tackle lung cancer in Europe, report says https://www.euractiv.com/section/health-consumers/news/disparities-remain-on-how-to-tackle-lung-cancer-in-europe-report-says/ https://www.euractiv.com/section/health-consumers/news/disparities-remain-on-how-to-tackle-lung-cancer-in-europe-report-says/#comments Wed, 05 Dec 2018 06:34:54 +0000 https://www.euractiv.com/?post_type=news&p=1296441 https://www.euractiv.com/section/health-consumers/news/disparities-remain-on-how-to-tackle-lung-cancer-in-europe-report-says/feed/ 1 Romanian health minister: Prevention and innovative drugs to kill cancer https://www.euractiv.com/section/health-consumers/news/romanian-health-minister-prevention-and-innovative-drugs-to-kill-cancer/ https://www.euractiv.com/section/health-consumers/news/romanian-health-minister-prevention-and-innovative-drugs-to-kill-cancer/#comments Tue, 04 Dec 2018 12:35:37 +0000 https://www.euractiv.com/?post_type=news&p=1296385 https://www.euractiv.com/section/health-consumers/news/romanian-health-minister-prevention-and-innovative-drugs-to-kill-cancer/feed/ 1 Greek pharma boss: ‘We reached our limits, our sustainability is at stake’ https://www.euractiv.com/section/health-consumers/interview/greek-pharma-boss-we-reached-our-limits-our-sustainability-is-at-stake/ https://www.euractiv.com/section/health-consumers/interview/greek-pharma-boss-we-reached-our-limits-our-sustainability-is-at-stake/#respond Tue, 04 Dec 2018 06:17:57 +0000 https://www.euractiv.com/?post_type=interview&p=1296054 https://www.euractiv.com/section/health-consumers/interview/greek-pharma-boss-we-reached-our-limits-our-sustainability-is-at-stake/feed/ 0 Does fast-track drugs approval in EU run too fast? https://www.euractiv.com/section/health-consumers/news/does-fast-track-drugs-approval-in-eu-run-too-fast/ https://www.euractiv.com/section/health-consumers/news/does-fast-track-drugs-approval-in-eu-run-too-fast/#respond Thu, 25 Oct 2018 04:51:23 +0000 https://www.euractiv.com/?post_type=news&p=1283901 https://www.euractiv.com/section/health-consumers/news/does-fast-track-drugs-approval-in-eu-run-too-fast/feed/ 0 EU generics industry slams US ‘intervention’ in SPC manufacturing waiver talks https://www.euractiv.com/section/health-consumers/news/eu-generics-industry-slams-us-intervention-in-spc-manufacturing-waiver-talks/ https://www.euractiv.com/section/health-consumers/news/eu-generics-industry-slams-us-intervention-in-spc-manufacturing-waiver-talks/#respond Tue, 23 Oct 2018 04:13:39 +0000 https://www.euractiv.com/?post_type=news&p=1283037 https://www.euractiv.com/section/health-consumers/news/eu-generics-industry-slams-us-intervention-in-spc-manufacturing-waiver-talks/feed/ 0 MEP: Need for an EU-wide cancer plan to ensure long-term pharma innovation https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/mep-need-for-an-eu-wide-cancer-plan-to-ensure-long-term-pharma-innovation/ https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/mep-need-for-an-eu-wide-cancer-plan-to-ensure-long-term-pharma-innovation/#comments Mon, 22 Oct 2018 09:43:13 +0000 https://www.euractiv.com/?post_type=news&p=1282856 https://www.euractiv.com/section/diabetes-cancer-hepatitis/news/mep-need-for-an-eu-wide-cancer-plan-to-ensure-long-term-pharma-innovation/feed/ 1 Innovation in oncology – Can science make cancer a manageable disease? https://www.euractiv.com/section/diabetes-cancer-hepatitis/video/innovation-in-oncology-can-science-make-cancer-a-manageable-disease/ https://www.euractiv.com/section/diabetes-cancer-hepatitis/video/innovation-in-oncology-can-science-make-cancer-a-manageable-disease/#comments Wed, 17 Oct 2018 10:22:02 +0000 https://www.euractiv.com/?post_type=video&p=1281328 https://www.euractiv.com/section/diabetes-cancer-hepatitis/video/innovation-in-oncology-can-science-make-cancer-a-manageable-disease/feed/ 1 New drugs: how much are governments paying for innovation? https://www.euractiv.com/section/health-consumers/news/new-drugs-how-much-are-governments-paying-for-innovation/ https://www.euractiv.com/section/health-consumers/news/new-drugs-how-much-are-governments-paying-for-innovation/#respond Wed, 10 Oct 2018 04:11:40 +0000 https://www.euractiv.com/?post_type=news&p=1278438 https://www.euractiv.com/section/health-consumers/news/new-drugs-how-much-are-governments-paying-for-innovation/feed/ 0 Estonia and Finland first to start exchanging healthcare data by end of year https://www.euractiv.com/section/health-consumers/news/fri-estonia-and-finland-first-to-start-exchanging-healthcare-data-by-end-of-year/ https://www.euractiv.com/section/health-consumers/news/fri-estonia-and-finland-first-to-start-exchanging-healthcare-data-by-end-of-year/#respond Fri, 05 Oct 2018 04:38:28 +0000 https://www.euractiv.com/?post_type=news&p=1276993 https://www.euractiv.com/section/health-consumers/news/fri-estonia-and-finland-first-to-start-exchanging-healthcare-data-by-end-of-year/feed/ 0 Europe’s health sector worried about post-Brexit investment dearth https://www.euractiv.com/section/health-consumers/news/europes-health-sector-warns-about-post-brexit-investment-dearth/ https://www.euractiv.com/section/health-consumers/news/europes-health-sector-warns-about-post-brexit-investment-dearth/#comments Mon, 01 Oct 2018 05:40:14 +0000 https://www.euractiv.com/?post_type=news&p=1275388 https://www.euractiv.com/section/health-consumers/news/europes-health-sector-warns-about-post-brexit-investment-dearth/feed/ 1 Investment in digital health and access to drugs at the core of Austrian Presidency https://www.euractiv.com/section/health-consumers/interview/investment-in-digital-health-and-access-to-drugs-at-the-core-of-austrian-presidency/ https://www.euractiv.com/section/health-consumers/interview/investment-in-digital-health-and-access-to-drugs-at-the-core-of-austrian-presidency/#respond Tue, 10 Jul 2018 09:34:25 +0000 https://www.euractiv.com/?post_type=interview&p=1255317 https://www.euractiv.com/section/health-consumers/interview/investment-in-digital-health-and-access-to-drugs-at-the-core-of-austrian-presidency/feed/ 0 EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation https://www.euractiv.com/section/health-consumers/interview/efpia-president-next-eu-commission-should-prioritise-competitiveness-in-pharma-innovation/ https://www.euractiv.com/section/health-consumers/interview/efpia-president-next-eu-commission-should-prioritise-competitiveness-in-pharma-innovation/#respond Tue, 03 Jul 2018 04:20:43 +0000 https://www.euractiv.com/?post_type=interview&p=1253179 https://www.euractiv.com/section/health-consumers/interview/efpia-president-next-eu-commission-should-prioritise-competitiveness-in-pharma-innovation/feed/ 0 ‘Vital’ UK remains part of EU clinical trials, say MPs https://www.euractiv.com/section/uk-europe/news/vital-uk-remains-part-of-eu-clinical-trials-say-mps/ https://www.euractiv.com/section/uk-europe/news/vital-uk-remains-part-of-eu-clinical-trials-say-mps/#respond Wed, 21 Mar 2018 06:59:08 +0000 https://www.euractiv.com/?post_type=news&p=1223474 https://www.euractiv.com/section/uk-europe/news/vital-uk-remains-part-of-eu-clinical-trials-say-mps/feed/ 0 EU and UK patients with rare diseases in Brexit limbo https://www.euractiv.com/section/health-consumers/news/eu-and-uk-patients-with-rare-diseases-in-brexit-limbo/ https://www.euractiv.com/section/health-consumers/news/eu-and-uk-patients-with-rare-diseases-in-brexit-limbo/#comments Fri, 02 Mar 2018 10:12:38 +0000 https://www.euractiv.com/?post_type=news&p=1217808 https://www.euractiv.com/section/health-consumers/news/eu-and-uk-patients-with-rare-diseases-in-brexit-limbo/feed/ 1 Health care risks being forgotten in Brexit talks, industry warns https://www.euractiv.com/section/health-consumers/news/health-care-risks-being-forgotten-in-brexit-talks-industry-warns/ https://www.euractiv.com/section/health-consumers/news/health-care-risks-being-forgotten-in-brexit-talks-industry-warns/#respond Thu, 22 Feb 2018 06:53:29 +0000 https://www.euractiv.com/?post_type=news&p=1215452 https://www.euractiv.com/section/health-consumers/news/health-care-risks-being-forgotten-in-brexit-talks-industry-warns/feed/ 0 EU unveils health technology bill https://www.euractiv.com/section/health-consumers/news/eu-unveils-health-technology-bill/ https://www.euractiv.com/section/health-consumers/news/eu-unveils-health-technology-bill/#respond Wed, 31 Jan 2018 17:19:06 +0000 https://www.euractiv.com/?post_type=news&p=1209316 https://www.euractiv.com/section/health-consumers/news/eu-unveils-health-technology-bill/feed/ 0 Fake medicines? Face 15 year jail term https://www.euractiv.com/section/health-consumers/news/fake-medicines-face-15-year-jail-term/ https://www.euractiv.com/section/health-consumers/news/fake-medicines-face-15-year-jail-term/#respond Mon, 29 Jan 2018 16:49:27 +0000 https://www.euractiv.com/?post_type=news&p=1208559 https://www.euractiv.com/section/health-consumers/news/fake-medicines-face-15-year-jail-term/feed/ 0 Health expert: Europe should not put its dominant pharma innovation at risk https://www.euractiv.com/section/health-consumers/interview/health-expert-europe-should-not-put-its-dominant-pharma-innovation-at-risk/ https://www.euractiv.com/section/health-consumers/interview/health-expert-europe-should-not-put-its-dominant-pharma-innovation-at-risk/#respond Mon, 29 Jan 2018 08:00:09 +0000 https://www.euractiv.com/?post_type=interview&p=1208229 https://www.euractiv.com/section/health-consumers/interview/health-expert-europe-should-not-put-its-dominant-pharma-innovation-at-risk/feed/ 0 Commission reforms meet with national ‘silence’, says frustrated EU health chief https://www.euractiv.com/section/health-consumers/news/commission-reforms-meet-with-national-silence-says-frustrated-eu-health-chief/ https://www.euractiv.com/section/health-consumers/news/commission-reforms-meet-with-national-silence-says-frustrated-eu-health-chief/#respond Thu, 25 Jan 2018 16:59:20 +0000 https://www.euractiv.com/?post_type=news&p=1207634 https://www.euractiv.com/section/health-consumers/news/commission-reforms-meet-with-national-silence-says-frustrated-eu-health-chief/feed/ 0 Health tech bill to kick off busy policy agenda in 2018 https://www.euractiv.com/section/health-consumers/news/health-tech-bill-to-kick-off-busy-policy-agenda-in-2018/ https://www.euractiv.com/section/health-consumers/news/health-tech-bill-to-kick-off-busy-policy-agenda-in-2018/#respond Wed, 24 Jan 2018 06:57:14 +0000 https://www.euractiv.com/?post_type=news&p=1206652 https://www.euractiv.com/section/health-consumers/news/health-tech-bill-to-kick-off-busy-policy-agenda-in-2018/feed/ 0 Stakeholders call for more transparent meetings between pharma and EMA https://www.euractiv.com/section/health-consumers/news/stakeholders-call-for-more-transparent-meetings-between-pharma-and-ema/ https://www.euractiv.com/section/health-consumers/news/stakeholders-call-for-more-transparent-meetings-between-pharma-and-ema/#respond Fri, 12 Jan 2018 15:33:17 +0000 https://www.euractiv.com/?post_type=news&p=1203835 https://www.euractiv.com/section/health-consumers/news/stakeholders-call-for-more-transparent-meetings-between-pharma-and-ema/feed/ 0 Commission reassures ‘worried’ member states on Health Technology Assessment https://www.euractiv.com/section/health-consumers/news/commission-reassures-worried-member-states-on-health-technology-assessment/ https://www.euractiv.com/section/health-consumers/news/commission-reassures-worried-member-states-on-health-technology-assessment/#respond Wed, 10 Jan 2018 05:13:25 +0000 https://www.euractiv.com/?post_type=news&p=1202821 https://www.euractiv.com/section/health-consumers/news/commission-reassures-worried-member-states-on-health-technology-assessment/feed/ 0 Drugs incentives have saved lives in Europe [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/drugs-incentives-have-saved-lives-in-europe/ https://www.euractiv.com/section/health-consumers/opinion/drugs-incentives-have-saved-lives-in-europe/#comments Tue, 12 Dec 2017 05:00:51 +0000 http://www.euractiv.com/?post_type=news&p=1198770 https://www.euractiv.com/section/health-consumers/opinion/drugs-incentives-have-saved-lives-in-europe/feed/ 1 Drug pricing debate to take place in heated atmosphere https://www.euractiv.com/section/health-consumers/news/drug-pricing-debate-to-take-place-in-heated-atmosphere/ https://www.euractiv.com/section/health-consumers/news/drug-pricing-debate-to-take-place-in-heated-atmosphere/#respond Fri, 08 Dec 2017 06:55:06 +0000 https://www.euractiv.com/?post_type=news&p=1198055 https://www.euractiv.com/section/health-consumers/news/drug-pricing-debate-to-take-place-in-heated-atmosphere/feed/ 0 Celgene boss: Chronic diseases will bankrupt Europe if incentives are dropped https://www.euractiv.com/section/health-consumers/interview/celgene-boss-chronic-diseases-will-bankrupt-europe-if-incentives-are-dropped/ https://www.euractiv.com/section/health-consumers/interview/celgene-boss-chronic-diseases-will-bankrupt-europe-if-incentives-are-dropped/#respond Thu, 07 Dec 2017 06:57:14 +0000 https://www.euractiv.com/?post_type=news&p=1197372 https://www.euractiv.com/section/health-consumers/interview/celgene-boss-chronic-diseases-will-bankrupt-europe-if-incentives-are-dropped/feed/ 0 UK and pharma industry call for transition period for medicines supply https://www.euractiv.com/section/health-consumers/news/uk-and-pharma-industry-call-for-transition-period-for-medicines-supply/ https://www.euractiv.com/section/health-consumers/news/uk-and-pharma-industry-call-for-transition-period-for-medicines-supply/#respond Wed, 29 Nov 2017 09:09:03 +0000 https://www.euractiv.com/?post_type=news&p=1195325 https://www.euractiv.com/section/health-consumers/news/uk-and-pharma-industry-call-for-transition-period-for-medicines-supply/feed/ 0 Athens brings its dispute with pharma industry to the EU Council https://www.euractiv.com/section/health-consumers/news/athens-brings-its-dispute-with-pharma-industry-to-the-eu-council/ https://www.euractiv.com/section/health-consumers/news/athens-brings-its-dispute-with-pharma-industry-to-the-eu-council/#comments Fri, 24 Nov 2017 11:30:36 +0000 https://www.euractiv.com/?post_type=news&p=1194205 https://www.euractiv.com/section/health-consumers/news/athens-brings-its-dispute-with-pharma-industry-to-the-eu-council/feed/ 1 Andriukaitis: National health systems need ‘fundamental reform’ https://www.euractiv.com/section/health-consumers/news/andriukaitis-national-health-systems-need-fundamental-reform/ https://www.euractiv.com/section/health-consumers/news/andriukaitis-national-health-systems-need-fundamental-reform/#comments Fri, 24 Nov 2017 06:15:26 +0000 https://www.euractiv.com/?post_type=news&p=1194136 https://www.euractiv.com/section/health-consumers/news/andriukaitis-national-health-systems-need-fundamental-reform/feed/ 1 EU health Commissioner Vytenis Andriukaitis discusses Europe’s superbug battlefront https://www.euractiv.com/section/health-consumers/video/europes-superbug-battlefront-an-interview-with-eu-health-commissioner-vytenis-andriukaitis/ https://www.euractiv.com/section/health-consumers/video/europes-superbug-battlefront-an-interview-with-eu-health-commissioner-vytenis-andriukaitis/#respond Mon, 13 Nov 2017 06:11:42 +0000 https://www.euractiv.com/?post_type=video&p=1190604 https://www.euractiv.com/section/health-consumers/video/europes-superbug-battlefront-an-interview-with-eu-health-commissioner-vytenis-andriukaitis/feed/ 0 EMA relocation should consider the wellbeing of all Europeans https://www.euractiv.com/section/health-consumers/opinion/ema-relocation-should-be-mindful-of-the-wellbeing-of-all-europeans/ https://www.euractiv.com/section/health-consumers/opinion/ema-relocation-should-be-mindful-of-the-wellbeing-of-all-europeans/#respond Fri, 10 Nov 2017 10:59:04 +0000 https://www.euractiv.com/?post_type=opinion&p=1190428 https://www.euractiv.com/section/health-consumers/opinion/ema-relocation-should-be-mindful-of-the-wellbeing-of-all-europeans/feed/ 0 Pharmaceutical company gives free access to drug after clash with Greek government https://www.euractiv.com/section/health-consumers/news/pharmaceutical-company-gives-free-access-to-drug-after-clash-with-greek-government/ https://www.euractiv.com/section/health-consumers/news/pharmaceutical-company-gives-free-access-to-drug-after-clash-with-greek-government/#comments Thu, 02 Nov 2017 05:30:17 +0000 https://www.euractiv.com/?post_type=news&p=1188247 https://www.euractiv.com/section/health-consumers/news/pharmaceutical-company-gives-free-access-to-drug-after-clash-with-greek-government/feed/ 2 Greek health minister fumes at pharmaceutical company after drug withdrawal https://www.euractiv.com/section/health-consumers/news/greek-health-minister-fumes-at-pharmaceutical-company-after-drug-withdrawal/ https://www.euractiv.com/section/health-consumers/news/greek-health-minister-fumes-at-pharmaceutical-company-after-drug-withdrawal/#respond Tue, 31 Oct 2017 06:17:38 +0000 https://www.euractiv.com/?post_type=news&p=1187921 https://www.euractiv.com/section/health-consumers/news/greek-health-minister-fumes-at-pharmaceutical-company-after-drug-withdrawal/feed/ 0 Pharmaceutical company withdraws oncology drug from Greek market https://www.euractiv.com/section/health-consumers/news/pharmaceutical-company-withdraws-oncology-drug-from-greek-market/ https://www.euractiv.com/section/health-consumers/news/pharmaceutical-company-withdraws-oncology-drug-from-greek-market/#respond Mon, 30 Oct 2017 12:22:19 +0000 https://www.euractiv.com/?post_type=news&p=1187748 https://www.euractiv.com/section/health-consumers/news/pharmaceutical-company-withdraws-oncology-drug-from-greek-market/feed/ 0